Blood tests may reveal hidden eye damage in diabetes

NCT ID NCT07434362

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study measured three substances in the blood (endocan, alarin, and galanin-like peptide) in people with and without diabetic retinopathy, an eye complication of diabetes. Researchers compared these levels across different stages of the disease and looked at how they relate to eye scan images. The goal was to see if these markers could help identify or track the severity of diabetic retinopathy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fethi Sekin City Hospital

    Elâzığ, Elaziğ, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.